Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

boostAGErx vs Meto

boostAGErx
Graded #183

Higher grade

vs+4.799999999999997
Meto
Graded #281

Lower grade

The verdict

boostAGErx takes it — 66.8/100 to 62/100.

boostAGErx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. boostAGErx is a longevity-focused telehealth brand offering compounded GLP-1 weight management (semaglutide and tirzepatide) starting around $95/mo on a 12-month upfront plan, plus peptide therapy such as…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueboostAGErx +29
74
45
Dose & formulationboostAGErx +37
77
40
Clinical oversightMeto +14
74
88
Labs & monitoringMeto +33
52
85
FulfillmentboostAGErx +2
69
67
Contract termsMeto +30
25
55
boostAGErx · left barMeto · right bar

The numbers

MetricboostAGErxMeto
WeighScore66.8/10062/100
GradeCC
Scorecard rank#183#281
Semaglutide$95/mo (starting dose, compounded)Not disclosed
Tirzepatide$95/mo (starting dose, compounded)Not disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
boostAGErx

Graded #183 · C

Strengths

  • Compounded GLP-1 starting around $95/mo (12-month plan paid upfront)
  • Free shipping and clinical evaluation included
  • Membership fee refunded in full if you're not approved
  • Also offers peptide therapy such as sermorelin
  • 100% online with licensed providers — no clinic visit

Where it loses points

  • Headline $95/mo requires a 12-month upfront commitment; actual price varies by product/plan
  • Compounded medications are non-refundable once dispensed
  • Pharmacy partner not named on the site
  • Not LegitScript-certified (no certification displayed)
  • States of operation not published
Meto

Graded #281 · C

Strengths

  • Accepts major insurance (Blue Cross, Anthem, United, Aetna) — most patients pay $0–50 per visit
  • Requires lab work before prescribing GLP-1s; addresses root-cause metabolic drivers
  • Matches patients with endocrinologists and obesity medicine specialists within minutes
  • Offers compounded semaglutide and tirzepatide with board-certified physician oversight
  • Handles all prior-auth paperwork; provider location pages exist for all 50 US states

Where it loses points

  • Medication pricing fully gated behind quiz — no public cash price for sema or tirz
  • Lab panels are a separate out-of-pocket cost ($199–$399) unless covered by insurance
  • No LegitScript certification or named compounding pharmacy found on any public page
  • Company leadership and clinical team not disclosed publicly
  • Self-pay cash pricing exists per site copy but is not published anywhere

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard